Abstracts

The Geriatric 8 score is associated with risk of hospitalisation and 6-month survival in patients with incurable pancreatic cancer receiving gemcitabine and capecitabine

Background Assessing frailty in cancer patients can aid treatment decisions, target geriatric interventions and improve outcomes. The G8 score is a screening tool to det...

06/27/2022

Ampullary neoplasms – how to treat in real-world practice? A retrospective study

Background Ampullary carcinomas are rare malignant tumours, originating at the complex of the ampulla of Vater. Surgery is the only potentially curative treatment and pr...

06/27/2022

Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumors sensitive to imatinib: A retrospective analysis of 2 Russian cancer centers

Background The role of cytoreductive surgery for patients with metastatic gastrointestinal stromal tumors (mGIST) responding to imatinib (IM) has not been established ye...

Lyudmila Zhukova ;

Petr Arkhiri ;

Maksim Nikulin ;

Igor Sagaidak ;

Vladimir Yugay ;

Andrey Meshcheryakov ;

Daria Filonenko ;

06/27/2022

Anti-EGFR antibodies may get benefit as first-line treatment in metastatic right-sided colon cancer

Background Location of the primary tumor can be prognostic and predictive of response to EGFR inhibitors as first-line treatment in mCRC suggesting that cetuximab and pa...

06/27/2022

DPYD evaluation and dose adjustment in patients with gastrointestinal cancer before initiation of fluoropyrimidine-based chemotherapy: One-centre experience

Background Fluoropyrimidines (FP) are the mainstay treatment of many neoplasms, especially the gastrointestinal (GI) tract cancers. Its metabolism is guaranteed by the e...

06/27/2022

Hepatocellular carcinoma: 9 years of experience in the medical oncology department at Mohammed VI University Hospital in Marrakech, Morocco

Background Hepatocellular carcinoma (HCC) is a primary malignant tumor of the liver, which remains asymptomatic for a long time. Diagnosis is most often late and its 5-y...

06/27/2022

Understanding the treatment algorithm of patients with advanced G2 gastroenteropancreatic neuroendocrine neoplasms: A single-institution retrospective analysis

Background Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are rare and heterogeneous malignancies and there is no consensus on treatment sequences, especia...

06/27/2022

OPTIMISE: Optimization of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomized approach with a run-in feasibility part

Background Patients with detectable circulating tumor DNA (ctDNA) after surgery for colorectal cancer are considered to have microscopic residual disease and consequentl...

06/27/2022

Local inflammatory biomarkers and their association with systemic inflammation as well as overall survival in primary metastatic gastroesophageal cancer patients

Background Immunotherapy has recently led to a major breakthrough in the treatment of metastatic gastroesophageal cancer patients. Yet, further analyses of large trials ...

06/27/2022

Left hemi-liver hypertrophy after right portal vein ligation versus embolization: A comparative study

Background In two-stage hepatectomy (TSH) for bilobar liver metastases from colorectal cancer, future liver remnant (FLR) growth can be achieved using several techniques...

06/27/2022